Cutaneous T cell lymphoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Cutaneous T cell lymphoma Classification and external resources | |
| ICD-10 | C84.0, C84.1 |
|---|---|
| ICD-9 | 202.1, 202.2 |
| ICD-O: | M9700/3, M9701/3 |
| DiseasesDB | 8595 |
| eMedicine | med/3486 |
| MeSH | D016410 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body are pushed to the surface of the skin in a biological process used to rid the body of offending material, causing various lesions to appear on the skin. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash and eventually forming plaques and tumors before metastatizing to other parts of the body.
Types
Though there are many types of CTCL and presentation can vary from individual to individual, there are two main forms:
- mycosis fungoides (MF)
- Sézary syndrome (SS)
There is some dispute over whether SS is an advanced form of MF or a different type of CTCL entirely - in either case, the prognosis for SS patients is substantially poorer than for those of MF.
Treatment
There is no cure for CTCL, but there are a variety of treatment options available and some CTCL patients are able to live somewhat normal lives with this cancer, although symptoms can be debilitating and painful, even in earlier stages.
Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin®) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H), Vorinostat (Zolinza®), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil®), Gemcitabine (Gemzar®), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation.
See also
External links
- Cutaneous T-Cell Lymphomas - The lymphoma Information Network
- The Cutaneous Lymphoma Foundation
- DermNet dermal-infiltrative/cutaneous-t-cell-lymphoma
- Lymphoma Research Foundation
- Cutaneous T-cell Lymphoma - H. Lee Moffitt Cancer Center & Research Institute
- UUHSC
- NCI Clinical Trial using Depsipeptide to treat CTCL
WikiDoc Research Resources for Cutaneous T cell lymphoma | |
|---|---|
| Articles on Cutaneous T cell lymphoma | Most recent articles on Cutaneous T cell lymphoma • Most cited articles on Cutaneous T cell lymphoma • Review articles on Cutaneous T cell lymphoma • Articles on Cutaneous T cell lymphoma in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Cutaneous T cell lymphoma | Powerpoint slides on Cutaneous T cell lymphoma • Images of Cutaneous T cell lymphoma • Photos of Cutaneous T cell lymphoma • Podcasts & MP3s on Cutaneous T cell lymphoma • Videos on Cutaneous T cell lymphoma |
| Evidence Based Medicine Regarding Cutaneous T cell lymphoma | Cochrane Collaboration on Cutaneous T cell lymphoma • Bandolier on Cutaneous T cell lymphoma • TRIP on Cutaneous T cell lymphoma |
| Cost Effectiveness of Cutaneous T cell lymphoma | Cost Effectiveness of Cutaneous T cell lymphoma |
| Clinical Trials Involving Cutaneous T cell lymphoma | Ongoing Trials on Cutaneous T cell lymphoma at Clinical Trials.gov • Trial results on Cutaneous T cell lymphoma • Clinical Trials on Cutaneous T cell lymphoma at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Cutaneous T cell lymphoma | US National Guidelines Clearinghouse on Cutaneous T cell lymphoma • NICE Guidance on Cutaneous T cell lymphoma • NHS PRODIGY Guidance • FDA on Cutaneous T cell lymphoma • CDC on Cutaneous T cell lymphoma |
| Textbook Information on Cutaneous T cell lymphoma | Books and Textbook Information on Cutaneous T cell lymphoma |
| Pharmacology Resources on Cutaneous T cell lymphoma | Dosing of Cutaneous T cell lymphoma • Drug interactions with Cutaneous T cell lymphoma • Side effects of Cutaneous T cell lymphoma • Allergic reactions to Cutaneous T cell lymphoma • Overdose information on Cutaneous T cell lymphoma • Carcinogenicity information on Cutaneous T cell lymphoma • Cutaneous T cell lymphoma in pregnancy • Pharmacokinetics of Cutaneous T cell lymphoma • |
| Genetics, Pharmacogenomics, and Proteinomics of Cutaneous T cell lymphoma | Genetics of Cutaneous T cell lymphoma • Pharmacogenomics of Cutaneous T cell lymphoma • Proteomics of Cutaneous T cell lymphoma |
| Newstories on Cutaneous T cell lymphoma | Cutaneous T cell lymphoma in the news • Be alerted to news on Cutaneous T cell lymphoma • News trends on Cutaneous T cell lymphoma |
| Commentary on Cutaneous T cell lymphoma | Blogs on Cutaneous T cell lymphoma |
| Patient Resources on Cutaneous T cell lymphoma | Patient resources on Cutaneous T cell lymphoma • Discussion groups on Cutaneous T cell lymphoma • Patient Handouts on Cutaneous T cell lymphoma • Directions to Hospitals Treating Cutaneous T cell lymphoma • Risk calculators and risk factors for Cutaneous T cell lymphoma |
| Healthcare Provider Resources on Cutaneous T cell lymphoma | Symptoms of Cutaneous T cell lymphoma • Causes & Risk Factors for Cutaneous T cell lymphoma • Diagnostic studies for Cutaneous T cell lymphoma • Treatment of Cutaneous T cell lymphoma |
| Continuing Medical Education (CME) Programs on Cutaneous T cell lymphoma | CME Programs on Cutaneous T cell lymphoma |
| International Resources on Cutaneous T cell lymphoma | Cutaneous T cell lymphoma en Espanol • Cutaneous T cell lymphoma en Francais |
| Business Resources on Cutaneous T cell lymphoma | Cutaneous T cell lymphoma in the Marketplace • Patents on Cutaneous T cell lymphoma |
| Informatics Resources on Cutaneous T cell lymphoma | List of terms related to Cutaneous T cell lymphoma |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

